Höfundar: Snædís Ragnarsdóttir

Adverse outcome of estrogen positive breast cancer patients with BRCA2 mutation

Adverse outcome of estrogen positive breast cancer patients with BRCA2 mutation

MITFs non-melanocyte role as a maintainer of genome integrity

Scroll to Top

Á þessu vefsvæði eru notaðar vafrakökur.